Lactobacillus helveticus producing antihypertensive di- and tripeptides
US6890529B1 · kind B1 · utility
4Cited by
7References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2000 |
| Grant date | May 10, 2005 |
| Priority date | — |
| Expiry date | Feb 27, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/225
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a new strain, Lactobacillus helveticus LBK-16 H, DSM 13137, and a bacterial preparation containing the same. The new strain Lactobacillus helveticus LBK-16 H has proteolytic activity and is capable of promoting the production of nitric oxide, and thus it is useful both as a starter bacterium in dairy industry and as a therapeutic substance as such and in various health-promoting products and pharmaceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.